Antibiotic therapy for pelvic inflammatory disease.
CONCLUSIONS: We found no conclusive evidence that one regimen of antibiotics was safer or more effective than any other for the cure of PID, and there was no clear evidence for the use of nitroimidazoles (metronidazole) compared to use of other drugs with activity over anaerobes. Moderate-quality evidence from a single study at low risk of bias suggested that a macrolide (azithromycin) may be more effective than a tetracycline (doxycycline) for curing mild-moderate PID. Our review considered only the drugs that are currently used and mentioned by the CDC.
PMID: 28436019 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: Journals (General) Authors: Savaris RF, Fuhrich DG, Duarte RV, Franik S, Ross J Tags: Cochrane Database Syst Rev Source Type: research
More News: Amoxicillin | Antibiotic Therapy | Augmentin | Azithromycin | Chlamydia | Clindamycin | Clinical Trials | Databases & Libraries | Doxycycline | General Medicine | International Medicine & Public Health | Men | Metronidazole | Science | STDs | Study | Tetracycline | WHO | Women | Zithromax